Sterline Bio Remedies Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 24-10-2024
- Paid Up Capital ₹ 1.84 Cr
as on 24-10-2024
- Company Age 10 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.75 Cr
as on 24-10-2024
- Revenue 16.71%
(FY 2023)
- Profit 18.74%
(FY 2023)
- Ebitda 7.91%
(FY 2023)
- Net Worth 11.64%
(FY 2023)
- Total Assets -2.24%
(FY 2023)
About Sterline Bio Remedies
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 1.84 Cr.
The company currently has active open charges totaling ₹6.75 Cr.
Palanki Rani and Veera Babu serve as directors at the Company.
- CIN/LLPIN
U05005AP2014PTC094797
- Company No.
094797
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jul 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Krishna, Andhra Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Sterline Bio Remedies Private Limited offer?
Sterline Bio Remedies Private Limited offers a wide range of products and services, including Bird Food, Poultry & Animal Food, Animal Feed Supplement, Fish Foods, Chemical Reagents & Catalysts, Inorganic Salts.
Who are the key members and board of directors at Sterline Bio Remedies?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Veera Babu  | Managing Director | 09-Jul-2014 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Palanki Rani | Director | 09-Jul-2014 | Current |
Financial Performance of Sterline Bio Remedies.
Sterline Bio Remedies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.71% increase. The company also saw a substantial improvement in profitability, with a 18.74% increase in profit. The company's net worth Soared by an impressive increase of 11.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sterline Bio Remedies?
In 2023, Sterline Bio Remedies had a promoter holding of 46.44% and a public holding of 53.56%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ordnc 2024 000022 U24230tg2022ptc166870 Private LimitedActive 2 years 4 monthsPalanki Rani is a mutual person
Charges (Loans)
₹6.75 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 5.75 Cr
- Others : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Oct 2017 | Others | ₹1.00 Cr | Open |
| 30 Mar 2016 | State Bank Of India | ₹4.95 Cr | Open |
| 13 Mar 2015 | State Bank Of India | ₹8.00 M | Open |
How Many Employees Work at Sterline Bio Remedies?
Sterline Bio Remedies has a workforce of 6 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sterline Bio Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sterline Bio Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.